Conditions: Type 2 Diabetes
Keywords: Dapagliflozin DPP IV inhibitor add on study Inadequate control
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 833
Healthy volunteers: no

Brief summary:
This study aims to investigate how dapagliflozin can control blood sugar in patients with type 2 diabetes when added to existing treatments (sitagliptin alone or in combination with metformin). The effect of dapagliflozin on weight and blood pressure will also be studied.

Detailed description:

Arms:
arm 1: Dapagliflozin 10 mg tablet arm 2: Matching placebo tablet

Interventions: intervention 1: Dapagliflozin intervention 2: Placebo
Intervention descriptions: intervention 1: 10 mg tablet, oral, once daily, 48 weeks intervention 2: Matching placebo tablet

Protocol document: